GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients
Conditions: Endometrial Neoplasms; Atypical Endometrial Hyperplasia; Progesterone Resistance; Obesity Interventions: Drug: GnRH antagonist; Drug: Letrozole 2.5mg Sponsors: Xiaojun Chen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
ALPINE: Maintenance Letrozole/Abemaciclib vs Pembrolizumab
Conditions: Endometrial Cancer; Recurrent Endometrial Cancer; TP53 Interventions: Drug: Abemaciclib; Drug: Letrozole; Drug: Pembrolizumab Sponsors: Dana-Farber Cancer Institute; Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding
Conditions: Endometrial Carcinoma Interventions: Other: Non-Interventional Study Sponsors: Mayo Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
Tislelizumab in Combination With Chemotherapy as a Neoadjuvant Treatment for Advanced Endometrial Cancer
Conditions: Endometrial Neoplasms Interventions: Drug: Tislelizumab; Drug: Paclitaxel; Drug: Carboplatin Sponsors: Zhongnan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
a SIngle Center Study of Post-operative STEReotactic RAdiotherapY for Endometrial Cancer
Conditions: Endometrial Cancer Interventions: Radiation: Stereotactic Post-operative Radiotherapy for Endometrial Cancer Sponsors: ARNAS Civico Di Cristina Benfratelli Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Improving Endometrial Cancer Assessment by Combining Genomic Profiling and Surgical Assessment
Conditions: Endometrial Cancer Interventions: Procedure: All women older than 18 newly diagnosed with endometrial cancer of all stages and histotypes Sponsors: University Hospital, Gasthuisberg; Fondazione Policlinico Universitario Agostino Gemelli IRCCS; University Medical Centre Maribor Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Predicting Response to Immune Checkpoint Inhibitors Across Solid Tumors Using a Live Tumor Diagnostic Platform
Conditions: Metastatic Cancer; NSCLC Stage IV; Non-small Cell Lung Cancer Stage IV; Small Cell Lung Cancer Metastatic; Solid Tumor; Clear Cell Renal Cell Carcinoma Metastatic; Urothelial Carcinoma Bladder; Cutaneous Malignant Melanoma; Castration-resistant Prostate Cancer; Prostate Cancer Metastatic; TNBC - Triple-Negative Breast Cancer; Breast Cancer Stage IV; Colon Cancer Stage IV; MSI-H Cancer; Cervical Cancer Stage IV; Endometrial Cancer Stage IV; Mismatch Repair-Deficient Endometrial Endometrioid Adenocarcinoma Interventions: Procedure: Biospecimen Collection; Procedure: Tissue Collection Sponsors: Mayo Clinic Not yet...
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
Medico-economic Evaluation of Robot-assisted Laparoscopy Compared With Conventional Laparoscopy in Hysterectomy for Endometrial Cancer.
Conditions: Hysterectomies for Low- or Intermediate-risk Endometrial Carcinoma Interventions: Procedure: Robot-assisted laparoscopy; Procedure: conventional laparoscopy; Other: Prospective cohort study; Other: Retrospective cohort study; Other: information and consent; Other: randomization; Other: Collection of socio-demographic, clinical, biological, imaging and histopathological data, treatment decision, recurrence; Other: Surgical data collection; Other: Biological data collection; Other: Collection of histological data from the surgical specimen; Other: Phone calls; Other: Pain assessment; Other: Collect of data on non...
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
Exploring the Potential of ctDNA-MRD for Recurrence Surveillance and Prognostic Evaluation in High-risk Endometrial Cancer
Conditions: Endometrial Cancer Interventions: Diagnostic Test: MRD-ctDNA Sponsors: The First Hospital of Jilin University; Geneplus-Beijing Co. Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
Conditions: Endometrial Cancer Interventions: Drug: BNT323/DB-1303; Drug: Doxorubicin; Drug: Paclitaxel Sponsors: BioNTech SE; DualityBio Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
ASk Questions in GYnecologic Oncology (ASQ-GYO)
Conditions: Ovarian Cancer; Endometrial Cancer; Cervical Cancer; Vulvar Cancer; Vaginal Cancer; Gestational Trophoblastic Disease Interventions: Behavioral: Administration of the ASk Questions in GYnecologic Oncology (ASQ-GYO) Question Prompt List Sponsors: Ira Winer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI
Conditions: Pancreatic Adenocarcinoma; Ampulla of Vater Carcinoma; Adrenocortical Carcinoma; Neuroendocrine Carcinoma; Soft Tissue Sarcoma; Small Bowel Adenocarcinoma; Duodenum Adenocarcinoma; Gastric Adenocarcinoma Interventions: Drug: Dostarlimab; Drug: Chemotherapy Sponsors: UNICANCER; National Cancer Institute, France; GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials
BAT1308 in Combination With Platinum-containing Chemotherapy is Used for the First-line Treatment of Advanced or Recurrent dMMR Endometrial Cancer
Conditions: Endometrial Cancer Interventions: Drug: carboplatin; Drug: Paclitaxel; Drug: Recombinant humanized anti-PD-1 monoclonal antibody injection Sponsors: Bio-Thera Solutions Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Japanese Participants With Primary Advanced or Recurrent Endometrial Cancer
Conditions: Carcinoma Interventions: Biological: Dostarlimab; Drug: Carboplatin; Drug: Paclitaxel Sponsors: GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2024 Category: Research Source Type: clinical trials
Effect of Physical Activity Intervention on Overweight and Obese Patients With Endometrial Cancer
Conditions: Endometrium Cancer; Physical Activity; Weight Management Interventions: Behavioral: Physical activity Sponsors: Peking University People ' s Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
